Urology combines in-office cystoscopy, OR surgery, and lab diagnostics. Each carries distinct coding and prior auth. We handle the mix without dropping the in-office work that moves fastest through claims.
We see the same patterns across urology groups. The leaks are specific, recurring, and fixable with coding discipline and payer-aware claim construction.
Not a complete list. A representative slice of the codes that drive revenue and denials for urology practices.
| Code | Description | Profile |
|---|---|---|
| 52000 | Cystourethroscopy, diagnostic | High volume |
| 52204 | Cystoscopy with biopsy | Modifier-sensitive |
| 55700 | Prostate biopsy | Denial-prone |
| 50590 | Extracorporeal shock wave lithotripsy | High volume |
| 52353 | Ureteroscopy with laser lithotripsy | Modifier-sensitive |
| 51741 | Complex uroflowmetry | Denial-prone |
| 51798 | Post-void residual by ultrasound | High volume |
Cystoscopy coded based on diagnostic vs therapeutic intent documented in the note. Prostate biopsy coordinated with in-house or outside pathology. BPH procedure prior auth workflow tracks UroLift, Rezum, TURP, and Aquablation payer rules.
Pattern we see. Cystoscopy coded as therapeutic when note supports only diagnostic, uroflow plus PVR bundling (some payers), and BPH procedure prior auth denied for incomplete IPSS and failed conservative therapy documentation.
How we fix it. Every denial is logged against its CARC/RARC code and routed to a coder who owns the appeal. We rebuild the claim with the documentation the payer is actually asking for, not a generic reconsideration letter. Recovery rate on appealable urology denials averages above 60 percent.
A written 30-day diagnostic. Dollar figures against every finding. No obligation.